The Effect of CME on Early Cancer Diagnosis in General Practice
The Effect of Continuing Medical Education (CME) on Early Cancer Diagnosis in General Practice
2 other identifiers
interventional
689
1 country
1
Brief Summary
Background Denmark has a lower survival of cancer compared to most European countries. Fast track pathways for organ specific cancers were established in the years 2008-2010. In 2011 further a fast track pathway for non-specific serious symptoms. Cancer in general practice is a low prevalence condition. Each general practitioner (GP) will see 8-10 new cancer patients per year. The investigators know that cancer patients have an increased use of general practice prior to diagnosis and that 25% of them wait for more than 20 days in general practice for referral according to the GPs. The latest Danish Cancer Plan therefore includes a CME as a key strategy to lower the GP threshold to refer patients to cancer fast track pathways. The aim of this study was to investigate the effect of this CME in early cancer diagnosis. This is measured by changes in GP knowledge, attitude and risk assessment. GP referral behavior assessed by primary care interval and use of fast track referrals. GP´s cancer hit rate, cancer patients´ tumor stage at treatment and 1 year survival. Methods/Design The study is conducted as a stepped wedge controlled design based on a quasi-cluster randomization. In august 2012 an invitation to participate in the present study were sent to 859 general Practitioners (GPs) from the Central Denmark Region. GPs completed a form for each patient they referred to a fast-track diagnostic pathway for cancer within an 8-month period. Every other week, we received data from a regional database. We reminded the referring GP-practice about non included patients. The collected data will be linked to registries. The CME-intervention The CME-course was a 3-hour meeting after work. Guided by the available evidence from the literature following the investigators ensured a multifaceted interactive teaching method including case-based education. The content included by other topics positive predictive values, false reassurance from negative testing and other pit-false. Statistical analyses The outcomes will be analyzed in a generalized linear random-effects model with random effect of GPs. Based on data it will be assessed whether further modeling of inter correlation within practices and within clusters is required, and whether the intervention effects are assumed equal for all GPs, or in random interaction with them. Analyses will be performed both in the full GP-population ("intention to intervening ") and in the 3 subgroups of GPs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started Sep 2012
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 29, 2014
CompletedFirst Posted
Study publicly available on registry
February 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMay 9, 2017
May 1, 2017
3.2 years
January 29, 2014
May 8, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary care interval
Primary care interval is the amount of days from the date where the patient first presented a cancer relevant symptom to the GP to the date of referral to a fast track pathway for cancer.
8 months
Secondary Outcomes (1)
Use of fast track referrals
8 months
Other Outcomes (7)
GP knowledge, attitude and likely behavior pre CME
Average 1 month before CME
Risk assessment
8 months
The concrete patient´s use of general practice half year prior to diagnosis
6 months
- +4 more other outcomes
Study Arms (2)
Continuing Medical Education
EXPERIMENTALContinuing Medical Education
Usual care
NO INTERVENTIONUsual care
Interventions
3-hour after work meeting. Multifaceted form. Content: Cancer symptoms positive predictive values, pit falls, reflections on barriers and attitudes towards early cancer diagnosis.
Eligibility Criteria
You may qualify if:
- GP should be a GP principal
- The referring GP should complete the registration form
You may not qualify if:
- Patients already registered with one cancer, diagnosed within 5 years
- Patients self-inflicted in delay
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Danish Committee for Health Educationcollaborator
- Danish College of General Practitionerscollaborator
Study Sites (1)
Research Centre for Cancer Diagnosis in Primary Care, Research Unit for General Practice, Aarhus University
Aarhus, Aarhus C, 8000, Denmark
Related Publications (3)
Toftegaard BS, Bro F, Falborg AZ, Vedsted P. Impact of a continuing medical education meeting on the use and timing of urgent cancer referrals among general practitioners - a before-after study. BMC Fam Pract. 2017 Mar 21;18(1):44. doi: 10.1186/s12875-017-0607-3.
PMID: 28327100DERIVEDToftegaard BS, Bro F, Falborg AZ, Vedsted P. Impact of continuing medical education in cancer diagnosis on GP knowledge, attitude and readiness to investigate - a before-after study. BMC Fam Pract. 2016 Jul 26;17:95. doi: 10.1186/s12875-016-0496-x.
PMID: 27460041DERIVEDToftegaard BS, Bro F, Vedsted P. A geographical cluster randomised stepped wedge study of continuing medical education and cancer diagnosis in general practice. Implement Sci. 2014 Nov 7;9:159. doi: 10.1186/s13012-014-0159-z.
PMID: 25377520DERIVED
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Peter Vedsted, PhD, Prof.
Research centre for Cancer Diagnosis in Primary Care (CaP), Research Unit for general practice, Aarhus University
- STUDY DIRECTOR
Flemming Bro, DrMed, Prof
Research Unit for General Practice, Aarhus University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2014
First Posted
February 24, 2014
Study Start
September 1, 2012
Primary Completion
December 1, 2015
Study Completion
December 1, 2016
Last Updated
May 9, 2017
Record last verified: 2017-05